T3 Uptake
T3 uptake is a calculated estimate of thyroid hormone binding protein availability that helps contextualize total thyroid hormone measurements - but it is widely misunderstood and frequently misinterpreted. It does not measure T3 levels directly. Its primary value is in calculating free thyroxine index, assessing thyroid-binding globulin status, and flagging conditions that alter protein binding and make total thyroid hormone values misleading.
Biomarker: T3 Uptake | Category: Thyroid | Abbreviation: T3U / THBR | Specimen: Serum
1. What Is T3 Uptake?
T3 uptake - also called resin T3 uptake or thyroid hormone binding ratio (THBR) - is one of the most frequently misunderstood tests in thyroid medicine. The name is deeply misleading: T3 uptake does not measure the concentration of triiodothyronine (T3) in your blood. It measures the availability of unoccupied thyroid hormone binding sites on serum proteins, primarily thyroid-binding globulin (TBG).
In the classic assay, a known quantity of radioactively or otherwise labeled T3 is added to the patient's serum. This labeled T3 competes with the patient's own thyroid hormones for available binding sites on TBG and other thyroid-binding proteins. What remains unbound attaches to a resin. The percentage that binds to the resin - and thus could not find a protein binding site - is reported as the T3 uptake value. A higher T3 uptake means fewer available binding sites, either because thyroid hormone levels are elevated (occupying more sites) or because TBG levels are reduced (fewer total sites). A lower T3 uptake means more available sites, either from low thyroid hormone or elevated TBG.
This counterintuitive relationship - where T3 uptake is high in hyperthyroidism and low in hypothyroidism - makes the test one of the most commonly misread values in thyroid evaluation. It moves in the same direction as thyroid hormone status, not inversely to it, because it reflects occupancy rather than availability from the patient's perspective.
2. Why the Test Exists - Historical Context
T3 uptake was developed in the 1950s as a tool to improve upon total T4 interpretation. Total T4 reflects both protein-bound and free thyroxine, but only the free fraction is biologically active. Conditions that alter TBG concentration - pregnancy, oral contraceptive use, liver disease, nephrotic syndrome, and certain medications - shift total T4 up or down independent of actual thyroid function, making total T4 unreliable in isolation.
The free thyroxine index (FTI): T3 uptake was designed to be multiplied by total T4 to produce the FTI - a calculated estimate of free T4 availability that corrects for TBG variation. When TBG is elevated (as in pregnancy), total T4 rises but T3 uptake falls, and the two effects roughly cancel in the FTI calculation. When TBG is reduced (as in nephrotic syndrome or androgen therapy), total T4 falls but T3 uptake rises, again producing an FTI that better reflects true free hormone status. Direct free T4 assays have largely replaced this calculation in modern practice.
3. Reference Ranges
| Result | Conventional Range | Clinical Interpretation |
|---|---|---|
| Normal | 24-39% | Normal binding protein availability; neither excess nor deficiency of thyroid hormone or TBG |
| High T3 uptake | Above 39% | Fewer available binding sites - suggests hyperthyroidism, low TBG, nephrotic syndrome, or androgen excess |
| Low T3 uptake | Below 24% | More available binding sites - suggests hypothyroidism, elevated TBG from estrogen, pregnancy, or liver disease |
Note: Reference ranges vary by laboratory and assay method. Some labs report T3 uptake as a ratio rather than a percentage. Always interpret against the reporting laboratory's established reference interval.
4. What High T3 Uptake Indicates
An elevated T3 uptake means that fewer binding sites are unoccupied - indicating that either thyroid hormone is abundant enough to fill most available sites, or that there are fewer total binding sites available. The most common causes:
- Hyperthyroidism: high circulating thyroid hormone occupies most TBG binding sites, leaving fewer free for the added labeled T3, so more goes to the resin
- Low TBG: reduced binding protein from androgen excess, anabolic steroid use, glucocorticoid therapy, or genetic TBG deficiency reduces total binding capacity, elevating T3 uptake independent of thyroid hormone levels
- Nephrotic syndrome: urinary TBG loss reduces binding protein availability and raises T3 uptake
- Severe systemic illness: non-thyroidal illness syndrome reduces TBG and shifts thyroid hormone binding patterns
- Certain medications: salicylates and other drugs compete for binding sites and can elevate T3 uptake
5. What Low T3 Uptake Indicates
A low T3 uptake means that more binding sites remain unoccupied - indicating either that thyroid hormone levels are insufficient to fill available sites, or that there are more total binding sites than normal. The most common causes:
- Hypothyroidism: low thyroid hormone leaves most TBG binding sites vacant; added labeled T3 fills protein sites rather than going to the resin, lowering measured T3 uptake
- Elevated TBG: estrogen - from pregnancy, oral contraceptives, or estrogen therapy - increases hepatic TBG production, expanding total binding capacity and lowering T3 uptake even when thyroid hormone levels are normal
- Liver disease: acute hepatitis increases TBG release, transiently lowering T3 uptake
- Genetic TBG excess: rare inherited condition producing abnormally high TBG and low T3 uptake without true hypothyroidism
6. T3 Uptake vs Free T3 - Critical Distinction
These are entirely different tests. Free T3 measures the biologically active, unbound fraction of triiodothyronine directly in serum. T3 uptake measures binding protein availability and does not reflect T3 concentration at all. Confusing these two values - which happens regularly in clinical settings - leads to serious misinterpretation. A patient with a high T3 uptake does not necessarily have high T3 levels; the elevation may reflect low TBG from medications or illness. Always verify which test result you are looking at.
| Feature | T3 Uptake | Free T3 |
|---|---|---|
| What it measures | Binding protein availability (unoccupied TBG sites) | Biologically active unbound triiodothyronine |
| Direction in hyperthyroidism | High (sites occupied) | High (more active hormone) |
| Direction in hypothyroidism | Low (sites vacant) | Low (less active hormone) |
| Affected by TBG changes | Yes - directly | Minimally with modern assays |
| Primary clinical use today | FTI calculation; TBG status assessment | Direct evaluation of active thyroid hormone |
| Part of functional thyroid panel | Optional; often omitted | Essential |
7. When T3 Uptake Remains Clinically Useful
In most modern functional medicine thyroid evaluations, T3 uptake has been superseded by direct free T4 and free T3 measurements. However, there are specific scenarios where T3 uptake continues to add value. When a patient's free T4 result appears discordant with their clinical presentation, checking T3 uptake alongside total T4 to calculate FTI can reveal whether a binding protein abnormality is distorting the free T4 assay. Certain free T4 immunoassays are susceptible to interference from abnormal binding proteins - T3 uptake and FTI provide a cross-check in these cases.
T3 uptake also helps contextualize thyroid panel results in patients on estrogen therapy, women who are pregnant or recently postpartum, patients with significant liver disease, and patients with known or suspected TBG abnormalities. In these populations, knowing the binding protein environment makes interpretation of total and free thyroid hormone values more reliable.
8. Interpreting T3 Uptake in a Complete Thyroid Panel
| Pattern | Most Likely Explanation |
|---|---|
| Low T3 uptake + high total T4 + normal TSH | Elevated TBG (pregnancy, estrogen therapy). Free T4 and FTI are likely normal. Not a thyroid disorder. |
| High T3 uptake + low total T4 + normal TSH | Low TBG (androgen therapy, nephrotic syndrome, genetic deficiency). Free T4 and FTI likely normal. Not a thyroid disorder. |
| Low T3 uptake + low total T4 + high TSH | True hypothyroidism - both binding protein status and hormone deficiency contributing to low total T4. |
| High T3 uptake + high total T4 + low TSH | True hyperthyroidism - hormone excess confirmed across multiple markers. |
| T3 uptake discordant with clinical picture | Consider binding protein abnormality, medication effect, or assay interference. Order direct free T4, free T3, and TBG measurement. |
9. Related Labs to Order Alongside T3 Uptake
Why does my lab report show T3 uptake if it does not measure T3?
The name is a legacy from when the test was introduced in the 1950s and reflects the methodology - labeled T3 is added and its uptake by a resin is measured. The name has persisted despite being consistently misleading. Many modern labs have renamed it thyroid hormone binding ratio (THBR) or resin uptake to reduce confusion, but older panel formats retain the original name. If you see T3 uptake on your results and wonder whether your T3 is being measured, the answer is no - that requires a separate free T3 or total T3 test.
Is T3 uptake still ordered routinely?
Less so than in previous decades. Most modern comprehensive thyroid panels include direct free T4 and free T3 measurements, which provide more clinically useful information about biologically active hormone levels without the interpretive complexity of T3 uptake. T3 uptake tends to appear on older-format panels, panels ordered through certain reference laboratories that include it by default, and in clinical situations where free hormone assay reliability is questioned due to binding protein abnormalities.
I am pregnant and my T3 uptake is low - is that a problem?
Low T3 uptake in pregnancy is expected and normal. Estrogen dramatically increases hepatic TBG production during pregnancy, expanding total binding capacity and leaving more unoccupied sites - which registers as a low T3 uptake. This does not indicate hypothyroidism. Your TSH and free T4 are the more clinically meaningful markers for thyroid function during pregnancy. A low T3 uptake in this context simply reflects the physiological binding protein changes of pregnancy, not a thyroid hormone deficiency.
T3 uptake is probably the most poorly named test in thyroid medicine. I have had patients come in convinced they have high T3 because their T3 uptake was elevated - but those are completely different things. When I see T3 uptake on a panel, I use it to understand the binding protein environment, particularly in patients on estrogen, and I calculate the free thyroxine index to cross-check the direct free T4 result. But in most cases, a well-ordered modern panel with TSH, free T3, free T4, and reverse T3 gives me everything I need without the interpretive confusion T3 uptake introduces.
Brian Lamkin, DO | Founder, The Lamkin Clinic | Edmond, Oklahoma
Content authored and clinically reviewed by Brian Lamkin, DO, founder of The Lamkin Clinic in Edmond, Oklahoma. Brian Lamkin, DO has 25+ years of experience in functional and regenerative medicine. This page reflects current functional medicine practice standards and is updated as new clinical evidence becomes available.
Get a Complete Thyroid Evaluation That Goes Beyond Standard Testing
A meaningful thyroid assessment includes TSH, free T3, free T4, reverse T3, and thyroid antibodies - not just a single marker. We build panels that give you the full picture of how your thyroid is actually functioning.
Schedule a ConsultationMedical Disclaimer: This content is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Lab interpretation should always be performed in clinical context by a qualified healthcare provider. Schedule a consultation to discuss your specific results with Dr. Lamkin.
